Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:663163rdf:typepubmed:Citationlld:pubmed
pubmed-article:663163lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:663163lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:663163lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:663163pubmed:issue3lld:pubmed
pubmed-article:663163pubmed:dateCreated1978-8-14lld:pubmed
pubmed-article:663163pubmed:abstractTextThe utility and limitations of 67Ga scintigraphy in children with solid tumors were evaluated. Thirty-five patients with malignancies (13 lymphoreticular neoplasms, 11 soft-tissue sarcomas, 8 neuroblastomas, and 3 primary bone tumors) had a 67Ga-citrate scan as part of their clinical evaluation. The sensitivity and specificity of the test were analyzed for the different tumor types. The overall sensitivity of the 67Ga-citrate scan for the lymphoma group was 87%. Higher values were obtained for the mediastinal and abdominal regions. Ninety-three per cent of the involved sites were correctly identified by 67Ga scintigraphy in the soft-tissue sarcoma group. Small lung metastases, however, were missed on scan. Thus, 67Ga scans should be complemented with chest radiographs and whole chest tomograms for both initial evaluation and follow-up in those patients. 67Ga had low sensitivity for neuroblastoma.lld:pubmed
pubmed-article:663163pubmed:languageenglld:pubmed
pubmed-article:663163pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:663163pubmed:citationSubsetAIMlld:pubmed
pubmed-article:663163pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:663163pubmed:statusMEDLINElld:pubmed
pubmed-article:663163pubmed:monthJunlld:pubmed
pubmed-article:663163pubmed:issn0033-8419lld:pubmed
pubmed-article:663163pubmed:authorpubmed-author:BekermanCClld:pubmed
pubmed-article:663163pubmed:authorpubmed-author:ThomA FAFlld:pubmed
pubmed-article:663163pubmed:authorpubmed-author:PaneGGlld:pubmed
pubmed-article:663163pubmed:authorpubmed-author:MoohrJ WJWlld:pubmed
pubmed-article:663163pubmed:authorpubmed-author:KranzlerJ KJKlld:pubmed
pubmed-article:663163pubmed:issnTypePrintlld:pubmed
pubmed-article:663163pubmed:volume127lld:pubmed
pubmed-article:663163pubmed:ownerNLMlld:pubmed
pubmed-article:663163pubmed:authorsCompleteYlld:pubmed
pubmed-article:663163pubmed:pagination719-25lld:pubmed
pubmed-article:663163pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-H...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-N...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-A...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-I...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-H...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-S...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-C...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-C...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-F...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-M...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-L...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-B...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-N...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-G...lld:pubmed
pubmed-article:663163pubmed:meshHeadingpubmed-meshheading:663163-S...lld:pubmed
pubmed-article:663163pubmed:year1978lld:pubmed
pubmed-article:663163pubmed:articleTitleScintigraphic evaluation of childhood malignancies by 67Ga-citrate.lld:pubmed
pubmed-article:663163pubmed:publicationTypeJournal Articlelld:pubmed